1. Home
  2. CBUS vs SEER Comparison

CBUS vs SEER Comparison

Compare CBUS & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cibus Inc.

CBUS

Cibus Inc.

HOLD

Current Price

$1.51

Market Cap

121.1M

Sector

Industrials

ML Signal

HOLD

Logo Seer Inc.

SEER

Seer Inc.

HOLD

Current Price

$1.98

Market Cap

97.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBUS
SEER
Founded
2010
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
121.1M
97.3M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
CBUS
SEER
Price
$1.51
$1.98
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$9.00
N/A
AVG Volume (30 Days)
799.0K
347.8K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
74.33
9.40
EPS
N/A
N/A
Revenue
$3,639,000.00
$16,578,000.00
Revenue This Year
$112.72
$2.14
Revenue Next Year
$83.18
$25.90
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.99
52 Week Low
$1.09
$1.65
52 Week High
$4.19
$2.41

Technical Indicators

Market Signals
Indicator
CBUS
SEER
Relative Strength Index (RSI) 37.44 63.86
Support Level $1.46 $1.87
Resistance Level $1.59 $2.13
Average True Range (ATR) 0.17 0.06
MACD 0.03 0.03
Stochastic Oscillator 31.88 80.52

Price Performance

Historical Comparison
CBUS
SEER

About CBUS Cibus Inc.

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

About SEER Seer Inc.

Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.

Share on Social Networks: